Noden Pharma Dac
Records under this name other than the patents Noden Pharma Dac holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,617,595 | Galenic Formulations of Organic Compounds Term ended Term ended Jul 2, 2026 · Medium confidence | Term ended | Term ended Jul 2, 2026 | Medium confidence |
| US 8,168,616 | Combination Comprising a Renin Inhibitor and an Angiotensin Receptor Inhibitor for Hypertension Lapsed on the fee record Ended May 1, 2024 · High confidence | Lapsed on the fee record | Ended May 1, 2024 | High confidence |
| US 8,183,295 | Pharmaceutical Composition Comprising a Renin Inhibitor, a Calcium Channel Blocker and a Diuretic Term ended Term ended May 16, 2023 · Medium confidence | Term ended | Term ended May 16, 2023 | Medium confidence |
| US 6,730,798 | Process for the preparation of substituted octanoyl amides Term ended Term ended Jan 18, 2023 · From the USPTO record | Term ended | Term ended Jan 18, 2023 | From the USPTO record |
| US 9,023,894 | Synergistic Combinations Comprising a Renin Inhibitor for Cardiovascular Diseases Term ended Term ended Sep 11, 2022 · Medium confidence | Term ended | Term ended Sep 11, 2022 | Medium confidence |
| US 9,023,893 | Synergistic Combinations Comprising a Renin Inhibitor for Cardiovascular Diseases Term ended Term ended Mar 3, 2022 · Medium confidence | Term ended | Term ended Mar 3, 2022 | Medium confidence |
| US 8,613,949 | Galenical Formulations of Organic Compounds Lapsed on the fee record Ended Dec 24, 2021 · High confidence | Lapsed on the fee record | Ended Dec 24, 2021 | High confidence |
| US 8,618,174 | Synergistic combinations comprising a renin inhibitor for cardiovascular diseases Term ended Ended no later than Nov 15, 2020 · From the USPTO record | Term ended | Ended no later than Nov 15, 2020 | From the USPTO record |
| US 7,153,675 | Process for the preparation of substituted carboxylic esters Lapsed on the fee record Ended Dec 26, 2018 · From the USPTO record | Lapsed on the fee record | Ended Dec 26, 2018 | From the USPTO record |
| US 7,132,569 | Preparation of N-substituted 2,7-dialkyl-4-hydroxy-5-amino-8-aryl-octanoyl amides Lapsed on the fee record Ended Nov 7, 2018 · From the USPTO record | Lapsed on the fee record | Ended Nov 7, 2018 | From the USPTO record |